Monitoring for endometrial disorders in 406 breast cancer women treated by tamoxifen. a low aggressive strategy.
Vosse
M
M
Gynaecologic Surgery Department, Jules Bordet Institute, Brussels, Belgium. jmfoidart@ulg.ac.be
Renard
F
F
Coibion
M
M
Nogaret
J M
JM
Hertens
D
D
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000000981:diagnostic imaging; D005260:Female; D006801:Humans; D013629:Tamoxifen / Q000009:adverse effects*; D014463:Ultrasonography
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen